Abstract
Medication-related osteonecrosis of the jaw (MRONJ) is an intractable adverse event. Dental implants are one of the triggering factors of MRONJ, and implant therapy with low MRONJ risk is required. This study aimed to investigate a rat model of MRONJ induced by extraoral placement of titanium materials and the use of mesenchymal stromal cell (MSCs) sheets to prevent MRONJ. Eight-week-old male rats were administered zoledronate and dexamethasone thrice weekly until killing. A week after drug initiation, a titanium screw and a plate were placed on the left buccal side of the mandible. Allogeneic bone marrow-derived MSC sheets were co-grafted with the titanium plates in the MSC sheet ( +) group. Six weeks after titanium placement, the rats were killed, and their excised mandibular bones were subjected to micro-computed tomography (CT) analysis. Histological analysis was performed after the titanium implants were removed. Empty lacunae visualized on hematoxylin and eosin staining were used as evidence of bone necrosis. Bone necrosis was reduced in the MSC sheet ( +) group. Tartrate-resistant acid phosphatase (TRAP) staining revealed a decreased number of TRAP-positive cells in areas with a large number of empty lacunae in the MSC sheet (–) group. Micro-CT analyses demonstrated that the bone volume fraction (BV/TV) was not significantly different between the MSC sheet (–) and ( +) groups. We conclude that MRONJ can be triggered by a titanium placement in rats, and grafting of allogeneic MSC sheets has the potential to prevent MRONJ.
Similar content being viewed by others
Data availability
The data of this study are available from the corresponding author on reasonable request.
References
Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American association of oral and maxillofacial surgeons’ position paper on medication-related osteonecrosis of the jaws—2022 update. J Oral Maxillofac Surg. 2022. https://doi.org/10.1016/j.joms.2022.02.008.
Marx P. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115–7. https://doi.org/10.1080/15426432.1979.10383302.
Kaibuchi N, Hoshi K, Yamazaki A, Miyamoto-Sangu N. Bone Reports The progress of medication-related osteonecrosis of the jaw with conservative initial treatment : a 12-year retrospective study of 129 patients. Bone Reports. 2021;14: 101072. https://doi.org/10.1016/j.bonr.2021.101072.
Voss PJ, Steybe D, Poxleitner P, Schmelzeisen R, Munzenmayer C, Fuellgraf H, et al. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis. Odontology. 2018;106:469–80. https://doi.org/10.1007/s10266-018-0362-5.
Aljohani S, Fliefel R, Ihbe J, Kühnisch J, Ehrenfeld M, Otto S. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a systematic review. J Cranio-Maxillofacial Surg. 2017;45:1493–502. https://doi.org/10.1016/j.jcms.2017.05.028.
Pichardo SEC, van der Hee JG, Fiocco M, Appelman-Dijkstra NM, van Merkesteyn JPR. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ). Br J Oral Maxillofac Surg. 2020;58:771–6. https://doi.org/10.1016/j.bjoms.2020.03.022.
Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N. Bisphosphonate-Related Osteonecrosis of the Jaw Associated With Dental Implants. J Oral Maxillofac Surg. 2010;68:790–6. https://doi.org/10.1016/j.joms.2009.09.017.
Schwarz F, Derks J, Monje A, Wang HL. Peri-implantitis. J Periodontol. 2018;89:S267–90. https://doi.org/10.1002/JPER.16-0350.
Fliefel R, Tro M, Ku J. Treatment strategies and outcomes of bisphosphonate- related osteonecrosis of the jaw ( BRONJ ) with characterization of patients : a systematic review. Int J Oral Maxillof Surg. 2015. https://doi.org/10.1016/j.ijom.2015.01.026.
Srinivasan M, Meyer S, Mombelli A, Müller F. Dental implants in the elderly population: a systematic review and meta-analysis. Clin Oral Implants Res. 2017;28:920–30. https://doi.org/10.1016/j.ijom.2015.01.026.
Schimmel M, Müller F, Suter V, Buser D. Implants for elderly patients. Periodontol 2000. 2017;73:228–40. https://doi.org/10.1111/prd.12166.
Inoue M, Matsumoto C, Nakajima K, Kuroshima S, Sawase T. Alendronate/dexamethasone combination therapy worsens soft and hard tissue wound healing around implants in rat maxillae. Bone. 2021;148: 115942. https://doi.org/10.1016/j.bone.2021.115942.
Park JY, Heo HA, Park S, Pyo SW. Enhancement of peri-implant bone formation via parathyroid hormone administration in a rat model at risk for medication-related osteonecrosis of the jaw. J Periodontal Implant Sci. 2020;50:121–31. https://doi.org/10.5051/jpis.2020.50.2.121.
Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9:11–5. https://doi.org/10.1016/j.stem.2011.06.008.
Lai RC, Arslan F, Lee MM, Sze NSK, Choo A, Chen TS, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4:214–22. https://doi.org/10.1016/j.scr.2009.12.003.
Cella L, Oppici A, Arbasi M, Moretto M, Piepoli M, Vallisa D, et al. Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw. Head Face Med. 2011;7:16. https://doi.org/10.1186/1746-160X-7-16.
Voss PJ, Matsumoto A, Alvarado E, Schmelzeisen R, Duttenhöfer F, Poxleitner P. Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells. Odontology. 2017;105:484–93. https://doi.org/10.1007/s10266-017-0295-4.
De Santis GC, de Macedo LD, Orellana MD, Innocentini LMAR, Ferrari TC, Ricz HMA, et al. Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: report of two cases. Acta Oncol (Madr). 2020;59:789–92. https://doi.org/10.1080/0284186X.2020.1730004.
Kondo M, Kameishi S, Grainger DW, Okano T. Novel therapies using cell sheets engineered from allogeneic mesenchymal stem/stromal cells. Emerg Top Life Sci. 2021;4:677–89. https://doi.org/10.1042/ETLS20200151.
Kim K, Bou-Ghannam S, Kameishi S, Oka M, Grainger DW, Okano T. Allogeneic mesenchymal stem cell sheet therapy: a new frontier in drug delivery systems. J Control Release. 2021;330:696–704. https://doi.org/10.1016/j.jconrel.2020.12.028.
Kato Y, Iwata T, Morikawa S, Yamato M, Okano T, Uchigata Y. Allogeneic transplantation of an adipose-derived stem cell sheet combined with artificial skin accelerates wound healing in a rat wound model of type 2 diabetes and obesity. Diabetes. 2015;64:2723–34. https://doi.org/10.2337/db14-1133.
Kaibuchi N, Iwata T, Yamato M, Okano T, Ando T. Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model. Acta Biomater. 2016;42:400–10. https://doi.org/10.1016/j.actbio.2016.06.022.
Kaibuchi N, Iwata T, Onizuka S, Yano K, Tsumanuma Y, Yamato M, et al. Allogeneic multipotent mesenchymal stromal cell sheet transplantation promotes healthy healing of wounds caused by zoledronate and dexamethasone in canine mandibular bones. Regen Ther. 2019;10:77–83. https://doi.org/10.1016/j.reth.2018.10.008.
Washio K, Tsutsumi Y, Tsumanuma Y, Yano K, Suphanantachat S, Takagi R, et al. In vivo periodontium formation around titanium implants using periodontal ligament cell sheet. Tissue Eng Part A. 2018;24:1273–82. https://doi.org/10.1089/ten.TEA.2017.0405.
Brooks AES, Iminitoff M, Williams E, Damani T, Jackson-Patel V, Fan V, et al. Ex vivo human adipose tissue derived mesenchymal stromal cells (ASC) are a heterogeneous population that demonstrate rapid culture-induced changes. Front Pharmacol. 2020;10:1695. https://doi.org/10.3389/fphar.2019.01695.
Howie RN, Borke JL, Kurago Z, Daoudi A, Cray J, Zakhary IE, et al. A model for osteonecrosis of the jaw with zoledronate treatment following repeated major trauma. PLoS ONE. 2015;10:e0132520. https://doi.org/10.1371/journal.pone.0132520.
Yong ZW, Guo J, Fa YW, Ying TZ, Lan X, Wang L, et al. Biodegradable magnesium implant enhances angiogenesis and alleviates medication-related osteonecrosis of the jaw in rats. J Orthop Transl. 2022;33:153–61. https://doi.org/10.1016/j.jot.2022.03.004.
Soma T, Iwasaki R, Sato Y, Kobayashi T, Ito E, Matsumoto T, et al. Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics. Sci Rep. 2022;12:19. https://doi.org/10.1038/s41598-021-03966-6.
Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin Oral Implants Res. 2014;25:632–40. https://doi.org/10.1111/clr.12088.
Ulrich D, Van Rietbergen B, Laib A, Ruegsegger P. The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone. 1999;25:55–60. https://doi.org/10.1016/S8756-3282(99)00098-8.
Sanda K, Ayukawa Y, Yasunami N, Adachi N, Furuhashi A, Imai M, et al. Therapeutic effect of fluvastatin on medication-related osteonecrosis of the jaw. J Periodontol. 2022;93:837–46. https://doi.org/10.1002/JPER.21-0294.
Soutome S, Yanamoto S, Sumi M, Hayashida S, Kojima Y, Sawada S, et al. Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery. J Bone Miner Metab. 2021;39:302–10. https://doi.org/10.1007/s00774-020-01154-6.
Wright A, Arthaud-Day ML, Weiss ML. Therapeutic use of mesenchymal stromal cells: the need for inclusive characterization guidelines to accommodate. all tissue sources and species. Front Cell Dev Biol. 2021;9: 632717. https://doi.org/10.3389/fcell.2021.632717.
Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22:824–33. https://doi.org/10.1016/j.stem.2018.05.004.
Galipeau J, Krampera M, Leblanc K, Nolta JA, Phinney DG, Shi Y, et al. Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition. Cytotherapy. 2021;23:368–72. https://doi.org/10.1016/j.jcyt.2020.11.007.
Kushiro H, Takahashi H, Tanaka A. Effects of the prevention of medication-related osteonecrosis of the jaw by local administration of a dental pulp stem cell-conditioned medium to the rat tooth extraction socket. Odontology. 2021;109:836–44. https://doi.org/10.1007/s10266-021-00607-2.
Kikuiri T, Kim I, Yamaza T, Akiyama K, Zhang Q, Li Y, et al. Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of thCelle jaw-like disease in mice. J Bone Miner Res. 2010;25:1668–79. https://doi.org/10.1002/jbmr.37.
Chow L, Johnson V, Impastato R, Coy J, Strumpf A, Dow S. Antibacterial activity of human mesenchymal stem cells mediated directly by constitutively secreted factors and indirectly by activation of innate immune effector cells. Stem Cells Transl Med. 2020;9:235–49. https://doi.org/10.1002/sctm.19-0092.
Nagase K, Yamato M, Kanazawa H, Okano T. Poly(N-isopropylacrylamide)-based thermoresponsive surfaces provide new types of biomedical applications. Biomaterials. 2018;153:27–48. https://doi.org/10.1016/j.biomaterials.2017.10.026.
Tatsumi K, Ohashi K, Matsubara Y, Kohori A, Ohno T, Kakidachi H, et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem Biophys Res Commun. 2013;431:203–9. https://doi.org/10.1016/j.bbrc.2012.12.134.
Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant Proc. 2007;39:573–6. https://doi.org/10.1016/j.transproceed.2006.12.019.
Bou-Ghannam S, Kim K, Grainger DW, Okano T. 3D cell sheet structure augments mesenchymal stem cell cytokine production. Sci Rep. 2021;11:8170. https://doi.org/10.1038/s41598-021-87571-7.
Thorp H, Kim K, Kondo M, Grainger DW, Okano T. Fabrication of hyaline-like cartilage constructs using mesenchymal stem cell sheets. Sci Rep. 2020;10:20869. https://doi.org/10.1038/s41598-020-77842-0.
Imafuku A, Oka M, Miyabe Y, Sekiya S, Nitta K, Shimizu T. Rat mesenchymal stromal cell sheets suppress renal fibrosis via microvascular protection. Stem Cells Transl Med. 2019;8:1330–41. https://doi.org/10.1002/sctm.19-0113.
Long T, Zhu Z, Awad HA, Schwarz EM, Hilton MJ, Dong Y. The effect of mesenchymal stem cell sheets on structural allograft healing of critical sized femoral defects in mice. Biomaterials. 2014;35:2752–9. https://doi.org/10.1016/j.biomaterials.2013.12.039.
Nakagawa T, Tsuka S, Aonuma F, Nodai T, Munemasa T, Tamura A, et al. Effects of metformin on the prevention of bisphosphonate-related osteonecrosis of the jaw-like lesions in rats. J Prosthodont Res. 2021;65:219–24. https://doi.org/10.2186/JPR.JPOR_2019_629.
De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem. 1995;270:15958–61. https://doi.org/10.1074/jbc.270.27.15958.
Malkawi AK, Alzoubi KH, Jacob M, Matic G, Ali A, Al Faraj A, et al. Metabolomics based profiling of Dexamethasone side effects in rats. Front Pharmacol. 2018;9:46. https://doi.org/10.3389/fphar.2018.00046.
Chruvattil R, Banerjee S, Nath S, Machhi J, Kharkwal G, Yadav MR, et al. Dexamethasone alters the appetite regulation via induction of hypothalamic insulin resistance in rat brain. Mol Neurobiol. 2017;54:7483–96. https://doi.org/10.1007/s12035-016-0251-2.
Sacco R, Umar R, Guerra RC, Akintola O. Evaluation of segmental mandibular resection without microvascular reconstruction in patients affected by medication-related osteonecrosis of the jaw: a systematic review. Br J Oral Maxillofac Surg. 2021;59:648–60. https://doi.org/10.1016/j.bjoms.2020.12.014.
Acknowledgements
We are indebted to Professor D. W. Grainger of the University of Utah, USA, for providing a technical review of this study. This work was partially supported by the Japan Society for the Promotion of Science (Grant Numbers 20K18681, 23K09362, and 18K09623).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflicts of interest.
Ethical approval
All animal experimental protocols used in this study were approved by the Animal Welfare Committee of Tokyo Women’s Medical University (agreement number AE21-021) and conducted according to all applicable institutional and/or national guidelines for the care and use of animals.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nishimaki, K., Kaibuchi, N., Washio, K. et al. Application of mesenchymal stromal cell sheets to prevent medication-related osteonecrosis of the jaw with titanium implants in rats. Odontology (2024). https://doi.org/10.1007/s10266-024-00900-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10266-024-00900-w